Victory Capital Management’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-422
| Closed | -$15.6K | – | 2542 |
|
|
2023
Q3 | $15.6K | Buy |
422
+19
| +5% | +$703 | ﹤0.01% | 2462 |
|
|
2023
Q2 | $16.2K | Sell |
403
-10
| -2% | -$403 | ﹤0.01% | 2459 |
|
|
2023
Q1 | $29.9K | Buy |
413
+2
| +0.5% | +$145 | ﹤0.01% | 2484 |
|
|
2022
Q4 | $33.7K | Hold |
411
| – | – | ﹤0.01% | 2483 |
|
|
2022
Q3 | $39K | Sell |
411
-46
| -10% | -$4.37K | ﹤0.01% | 2582 |
|
|
2022
Q2 | $89K | Buy |
457
+17
| +4% | +$3.31K | ﹤0.01% | 2471 |
|
|
2022
Q1 | $70K | Sell |
440
-13
| -3% | -$2.07K | ﹤0.01% | 2562 |
|
|
2021
Q4 | $178K | Buy |
453
+11
| +2% | +$4.32K | ﹤0.01% | 2504 |
|
|
2021
Q3 | $198K | Sell |
442
-51
| -10% | -$22.8K | ﹤0.01% | 2528 |
|
|
2021
Q2 | $192K | Sell |
493
-12
| -2% | -$4.67K | ﹤0.01% | 2532 |
|
|
2021
Q1 | $181K | Sell |
505
-19
| -4% | -$6.81K | ﹤0.01% | 2536 |
|
|
2020
Q4 | $257K | Buy |
524
+80
| +18% | +$39.2K | ﹤0.01% | 2326 |
|
|
2020
Q3 | $144K | Sell |
444
-9
| -2% | -$2.92K | ﹤0.01% | 2320 |
|
|
2020
Q2 | $165K | Sell |
453
-301
| -40% | -$110K | ﹤0.01% | 2322 |
|
|
2020
Q1 | $160K | Buy |
754
+339
| +82% | +$71.9K | ﹤0.01% | 2389 |
|
|
2019
Q4 | $171K | Buy |
415
+99
| +31% | +$40.8K | ﹤0.01% | 2349 |
|
|
2019
Q3 | $112K | Buy |
+316
| New | +$112K | ﹤0.01% | 2399 |
|